跳至主要内容
临床试验/EUCTR2019-004297-26-EE
EUCTR2019-004297-26-EE进行中(未招募)1 期

Prophylactic treatment of the ductus arteriosus in preterm infants by acetaminophen - TREOCAPA

Institut National de la Santé et de la Recherche Médicale (INSERM)0 个研究点目标入组 824 人开始时间: 2020年5月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
824

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • ? Birth between 23-26 W for Phase II, between 23-28 W for Phase III
  • ? Post natal age < 12 hours
  • ? Parental or Legal Authority Consent
  • ? Parents with a social security or health insurance (if applicable)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 824
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ? Birth defect / Congenital anomaly
  • ? Twin-to-twin transfusion syndrome
  • ? Suspicion of pulmonary hypoplasia
  • ?Suspicion of hepatic impairment (hemorrhagic syndrome and/or severe hypoglycemia)
  • ? Clinical instability that can lead to rapid death
  • ? Impossibility to start treatment before 12 hours of life
  • ? Parents placed under judicial protection
  • ? Participation in other clinical trial using acetaminophen during the first 5 days of life, indomethacin or ibuprofen during the first 3 days of life or using rescue treatment of PDA not recommended in the TREOCAPA trial

研究者

发起方
Institut National de la Santé et de la Recherche Médicale (INSERM)

相似试验